Medicare Enrolled

Dr. Faisal Chaudhary, M.D.

Optician · Saratoga Springs, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
6 CARE LANE, Saratoga Springs, NY 12866
5185844953
In practice since 2008 (18 years)
NPI: 1194986257 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chaudhary from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chaudhary? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chaudhary

Dr. Faisal Chaudhary is an optician specialist in Saratoga Springs, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Chaudhary performed 84,717 Medicare services across 1,047 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chaudhary received a total of $21,010 from 44 pharmaceutical and/or device companies across 896 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chaudhary is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 0% volume in NY $21,010 industry payments

Medicare Practice Summary

Medicare Utilization ↗
84,717
Medicare services
Top 0% in NY for optician
1,047
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,706 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 49,400 $5 $9
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
17,431 $11 $50
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
6,551 $34 $99
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
5,730 $26 $174
Denosumab injection (Prolia/Xgeva) 3,300 $18 $34
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
579 $86 $250
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
399 $1 $26
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
332 $101 $500
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
264 $1 $11
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
185 $56 $200
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
141 $8 $10
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
111 $22 $300
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
72 $113 $375
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
67 $48 $350
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
56 $11 $50
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
46 $54 $333
New patient office visit, complex (60-74 min) 34 $156 $425
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
19 $50 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
36.0% high complexity
62.8% medium
1.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$21,010
Total received (2018-2024)
Avg $3,001/year across 7 years
Top 8% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
896
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,820 (70.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,190 (29.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,274
2023
$3,389
2022
$2,196
2021
$28
2020
$838
2019
$8,697
2018
$2,588

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$601
UCB, Inc.
$381
Janssen Biotech, Inc.
$321
Amgen Inc.
$311
GlaxoSmithKline, LLC.
$244
PFIZER INC.
$241
Octapharma USA, Inc.
$110
Sandoz Inc.
$108
Lilly USA, LLC
$107
Novartis Pharmaceuticals Corporation
$104
Actelion Pharmaceuticals US, Inc.
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
Fresenius Kabi USA, LLC
$79
Aurinia Pharma U.S., Inc.
$77
E.R. Squibb & Sons, L.L.C.
$67
ANI Pharmaceuticals, Inc.
$66
Mallinckrodt Hospital Products Inc.
$49
SOBI, INC
$40
Teva Pharmaceuticals USA, Inc.
$37
Kiniksa Pharmaceuticals International, plc
$27
Organon Llc
$26
SCILEX PHARMACEUTICALS INC.
$24
GENZYME CORPORATION
$22
DePuy Synthes Sales Inc.
$22
AstraZeneca Pharmaceuticals LP
$19
Genentech USA, Inc.
$15
Top 3 companies account for 39.8% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$6,550
Amgen Inc.
$1,688
Janssen Biotech, Inc.
$1,550
UCB, Inc.
$1,445
PFIZER INC.
$1,406
ABBVIE INC.
$1,201
Novartis Pharmaceuticals Corporation
$994
GlaxoSmithKline, LLC.
$919
Genentech USA, Inc.
$730
AbbVie Inc.
$718
Lilly USA, LLC
$476
Mallinckrodt Hospital Products Inc.
$442
E.R. Squibb & Sons, L.L.C.
$339
Boehringer Ingelheim Pharmaceuticals, Inc.
$260
Horizon Therapeutics plc
$223
Aurinia Pharma U.S., Inc.
$198
Actelion Pharmaceuticals US, Inc.
$195
Fresenius Kabi USA, LLC
$177
AstraZeneca Pharmaceuticals LP
$148
Sandoz Inc.
$127
Octapharma USA, Inc.
$110
Takeda Pharmaceuticals U.S.A., Inc.
$104
GENZYME CORPORATION
$96
Horizon Pharma plc
$88
SOBI, INC
$81
Hikma Pharmaceuticals USA
$81
Celgene Corporation
$68
Radius Health, Inc.
$66
ANI Pharmaceuticals, Inc.
$66
Antares Pharma, Inc.
$66
Organon LLC
$50
Kiniksa Pharmaceuticals, Ltd.
$48
Sobi, Inc
$37
Teva Pharmaceuticals USA, Inc.
$37
Fidia Pharma USA Inc.
$33
Kiniksa Pharmaceuticals International, plc
$27
Organon Llc
$26
Alexion Pharmaceuticals, Inc.
$24
SCILEX PHARMACEUTICALS INC.
$24
Novo Nordisk Inc
$24
DePuy Synthes Sales Inc.
$22
Merck Sharp & Dohme Corporation
$18
Bayer HealthCare Pharmaceuticals Inc.
$16
Mallinckrodt Enterprises LLC
$12
Top 3 companies account for 46.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Adempas · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · EVUSHELD · Enbrel · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SOLIRIS · STELARA · TALTZ · TAVNEOS · TREMFYA · Truxima · Tymlos · UPTRAVI · Uloric · Wegovy · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for optician in NY.

Looking for an optician specialist in Saratoga Springs?
Compare opticians in the Saratoga Springs area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
460
Per 100K population
194.0
County median income
$99,653
Nearest hospital
SARATOGA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chaudhary is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with low-engagement industry engagement in the top 8% of NY peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chaudhary experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Chaudhary performed 49,400 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chaudhary receive payments from pharmaceutical companies?
Yes. Dr. Chaudhary received a total of $21,010 from 44 companies across 896 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chaudhary's costs compare to other opticians in Saratoga Springs?
Dr. Chaudhary's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chaudhary) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →